These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7849681)

  • 1. New protocols for perioperative management of podiatric patients taking oral anticoagulants.
    Mandracchia VJ; Evans RD; Sticha R
    J Foot Ankle Surg; 1994; 33(5):526. PubMed ID: 7849681
    [No Abstract]   [Full Text] [Related]  

  • 2. New protocols for perioperative management of podiatric patients taking oral anticoagulants.
    Lanzat M; Danna AT; Jacobson DS
    J Foot Ankle Surg; 1994; 33(1):16-20. PubMed ID: 8161987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of anticoagulant and antiplatelet therapy. Managing patients with acute thrombotic disorders.
    Anderson DR; Fernandez LA
    Can Fam Physician; 1993 Feb; 39():290-4, 297-300, 303-4. PubMed ID: 8495120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of perioperative low molecular weight heparin substitution in patients on chronic oral anticoagulant therapy undergoing transurethral prostatectomy for bladder outlet obstruction.
    Dotan ZA; Mor Y; Leibovitch I; Varon D; Golomb J; Duvdevani M; Ramon J
    J Urol; 2002 Aug; 168(2):610-3; discussion 614. PubMed ID: 12131319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical venous limb gangrene complicating oral anticoagulation in a patient with cancer-associated deep venous thrombosis.
    Georgin S; Pouchot J; Raschilas F; Barete S; Lerolle DL; Vinceneux P
    Arch Dermatol; 2003 Sep; 139(9):1126-8. PubMed ID: 12975152
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug therapy of deep venous thrombosis].
    Bounameaux H
    Ther Umsch; 1996 Apr; 53(4):272-6. PubMed ID: 8658349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A standardized weight-based heparin protocol. Improving clinical outcomes.
    Lechner DL
    Nurs Manage; 1997 Apr; 28(4):29-32. PubMed ID: 9287775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomograms for the administration of unfractionated heparin in the initial treatment of acute thromboembolism--an overview.
    Bernardi E; Piccioli A; Oliboni G; Zuin R; Girolami A; Prandoni P
    Thromb Haemost; 2000 Jul; 84(1):22-6. PubMed ID: 10928464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The impact of heparin bolus from dysfunctional lumen of dual lumen central venous catheter on activated partial thromboplastin time during hemodialysis: is additional heparinization necessary?].
    Sefer S; Kes P; Raić B; Heinrich B; Degoricija V; Szavits-Nossan J
    Acta Med Croatica; 2006 Jun; 60(3):281-5. PubMed ID: 16933844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry.
    Spyropoulos AC; Turpie AG; Dunn AS; Spandorfer J; Douketis J; Jacobson A; Frost FJ;
    J Thromb Haemost; 2006 Jun; 4(6):1246-52. PubMed ID: 16706967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of thrombosis during pregnancy.
    Vilela VS; de Jesús NR; Levy RA
    Isr Med Assoc J; 2002 Oct; 4(10):794-7. PubMed ID: 12389343
    [No Abstract]   [Full Text] [Related]  

  • 14. Continuous administration of heparin in patients with deep vein thrombosis can increase plasma levels of diamine oxidase.
    Klocker J; Perkmann R; Klein-Weigel P; Mörsdorf G; Drasche A; Klingler A; Fraedrich G; Schwelberger HG
    Vascul Pharmacol; 2004 Jan; 40(6):293-300. PubMed ID: 15063833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
    Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
    Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anticoagulation in stroke. Evidence-based and empirical indications].
    Walter U; Kloth A; Benecke R; Kunesch E
    Dtsch Med Wochenschr; 2003 Oct; 128(42):2200-5. PubMed ID: 14562219
    [No Abstract]   [Full Text] [Related]  

  • 18. Advances in prostacyclin therapy for pulmonary arterial hypertension.
    Eells PL
    Crit Care Nurse; 2004 Apr; 24(2):42-8, 50-4. PubMed ID: 15098310
    [No Abstract]   [Full Text] [Related]  

  • 19. [Subcutaneous heparinotherapy. Clinical study of calcium heparinate].
    Warembourg H; Bertrand M
    Lille Med; 1968 Dec; 13(10):Suppl 7:1057+. PubMed ID: 5720291
    [No Abstract]   [Full Text] [Related]  

  • 20. Experience with heparin dosing at Christchurch Hospital.
    Ward ML; Duffull SB
    N Z Med J; 1998 Jun; 111(1068):228-30. PubMed ID: 9695751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.